eli lilly semaglutide drug Ozempic maker slumps further in fight with Lilly, Zepbound Novo Nordisk and Eli Lilly

Kidney protection: the FLOW trial The FLOW trial studied semaglutide in patients with type 2 diabetes and chronic kidney disease

Retatrutide's half-life of approximately 6 days supports this weekly schedule

This all-in-one water bottle uses two-stage purification to filter out contaminants and up to 99.99 percent of bacteria (including E

References: IQVIA LAAD pharmacy claims data, US Market Access Strategy Consulting analysis Eli Lilly Tightens Access to Diabetes Drug, Frustrating Some People with Obesity, STAT News New Demand in an Old Market Read part 2 of this blog series to learn how the launch of Mounjaro transformed the GLP-1 market and led to the emergence of a new type of patient access profile thats challenging todays traditional diabetes care paradigm